glp 1 agonist ppt GLP1 ANALOGUES- BEYOND DIABETES.pptx glp 1 ppt The Emerging
Description
GLP-1 drugs have become a game-changer in treating obesity and type 2 diabetes, forecast to reach a $100 billion market value by 2030
With the emergence of various classes of blood glucose-lowering agents, choosing the appropriate drug for each patient is emphasized in diabetes management
At 12 months, weight loss persisted at around 4%, with variability between agents, most notably liraglutide
The data are provided by patients and collected by the UK National Health Service as part of their care and support
The messaging is about affordability and access
All Day
